BICD1 expression, as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas

There is variation in the survival and therapeutic outcome of patients with glioblastomas (GBMs). Therapy resistance is an important challenge in the treatment of GBM patients. The aim of this study was to identify Temozolomide (TMZ) related genes and confirm their clinical relevance. The TMZ-relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shang-Pen, Chang, Yu-Chan, Low, Qie Hua, Wu, Alexander T.H., Chen, Chi-Long, Lin, Yuan-Feng, Hsiao, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768362/
https://www.ncbi.nlm.nih.gov/pubmed/29371945
http://dx.doi.org/10.18632/oncotarget.22667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768362/
https://www.ncbi.nlm.nih.gov/pubmed/29371945
http://dx.doi.org/10.18632/oncotarget.22667

Ejemplares similares